Health
Chennai-based Iswarya Fertility Center has raised over ₹350 crore (approximately $37 million) in a growth investment from OrbiMed Asia, a leading global healthcare investment firm.
The funding will support the company's next phase of expansion by establishing new fertility centres across existing and underserved markets, upgrading clinical infrastructure, strengthening digital capabilities, and expanding its embryology workforce to meet rising demand for advanced reproductive healthcare services.
As infertility care continues to gain greater attention in India, the investment is expected to enhance patient access to specialized fertility treatments while supporting technology-driven clinical excellence and improved healthcare delivery.
The transaction also highlights growing investor confidence in India's fertility and reproductive healthcare sector, driven by increasing awareness, improving healthcare infrastructure, and rising demand for specialized medical services.
